A prospective pilot study of biofeedback training with Contrain” in patients with major Low Anterior Resection Syndrome (LARS) and faecal incontinence symptoms after anterior resection for rectal cancer

Not Applicable

Recruiting

• Conditions: ow anterior resection syndrome; Faecal Incontinence; Low anterior resection syndrome; Cancer - Bowel - Back passage (rectum) or large bowel (colon)

• Registration Number: ACTRN12623001178639
• Lead Sponsor: niversity of Otago

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-11-14
• Last Update Posted: 20 November 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

1. Previous rectal cancer surgery
2. Full continuity of the gastrointestinal tract (If a stoma was formed it has subsequently been closed at least a year prior to enrolment in this study)
3. Major LARS (score > 30)
4. Previous treatment has been given for LARS, including medications such as loperamide, dietary advice and treatment for bile acid malabsorption (BAM).
5. Aged 18-80
6. Able to give informed consent
7. Participant is available to commit to up to 36 weeks of biofeedback training.
8. Participant is sufficiently motivated to commit to two training sessions a day for 6-9 months.

Exclusion Criteria

Cognitive disorders impeding pelvic floor rehabilitation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified